Reference
1. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of
atrial fibrillation by ectopic beats originating in the pulmonary veins.N Engl J Med. 1998;339(10):659-666.
2. Khan AR, Khan S, Sheikh MA, Khuder S, Grubb B, Moukarbel GV. Catheter
ablation and antiarrhythmic drug therapy as first- or second-line
therapy in the management of atrial fibrillation: systematic review and
meta-analysis. Circ Arrhythm Electrophysiol. 2014;7(5):853-860.
3. Cappato R, Marchlinski FE, Hohnloser SH, et al. Uninterrupted
rivaroxaban vs. uninterrupted vitamin K antagonists for catheter
ablation in non-valvular atrial fibrillation. Eur Heart J.2015;36(28):1805-1811.
4. Calkins H, Willems S, Gerstenfeld EP, et al. Uninterrupted Dabigatran
versus Warfarin for Ablation in Atrial Fibrillation. N Engl J
Med. 2017;376(17):1627-1636.
5. Kirchhof P, Haeusler KG, Blank B, et al. Apixaban in patients at risk
of stroke undergoing atrial fibrillation ablation. Eur Heart J.2018;39(32):2942-2955.
6. Hohnloser SH, Camm J, Cappato R, et al. Uninterrupted edoxaban vs.
vitamin K antagonists for ablation of atrial fibrillation: the
ELIMINATE-AF trial. Eur Heart J. 2019;40(36):3013-3021.
7. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the
diagnosis and management of atrial fibrillation developed in
collaboration with the European Association of Cardio-Thoracic Surgery
(EACTS). Eur Heart J. 2020.
8. Calkins H, Hindricks G, Cappato R, et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Heart Rhythm.2017;14(10):e275-e444.
9. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequency
Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med.2016;374(23):2235-2245.
10. Kuck KH, Furnkranz A, Chun KR, et al. Cryoballoon or radiofrequency
ablation for symptomatic paroxysmal atrial fibrillation: reintervention,
rehospitalization, and quality-of-life outcomes in the FIRE AND ICE
trial. Eur Heart J. 2016;37(38):2858-2865.
11. Aryana A, Singh SM, Kowalski M, et al. Acute and Long-Term Outcomes
of Catheter Ablation of Atrial Fibrillation Using the Second-Generation
Cryoballoon versus Open-Irrigated Radiofrequency: A Multicenter
Experience. J Cardiovasc Electrophysiol. 2015;26(8):832-839.
12. Squara F, Zhao A, Marijon E, et al. Comparison between
radiofrequency with contact force-sensing and second-generation
cryoballoon for paroxysmal atrial fibrillation catheter ablation: a
multicentre European evaluation. Europace. 2015;17(5):718-724.
13. Ciconte G, Baltogiannis G, de Asmundis C, et al. Circumferential
pulmonary vein isolation as index procedure for persistent atrial
fibrillation: a comparison between radiofrequency catheter ablation and
second-generation cryoballoon ablation. Europace.2015;17(4):559-565.
14. Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin
in patients with atrial fibrillation. N Engl J Med.2013;369(22):2093-2104.
15. Briceno DF, Villablanca PA, Lupercio F, et al. Clinical Impact of
Heparin Kinetics During Catheter Ablation of Atrial Fibrillation:
Meta-Analysis and Meta-Regression. J Cardiovasc Electrophysiol.2016;27(6):683-693.
16. Payne JE, Koerber SM, Bickel T, Ghadban R, Flaker G, Gautam S.
Higher initial weight-based heparin dosing is required with direct oral
anticoagulants during catheter ablation for atrial fibrillation. J
Interv Card Electrophysiol. 2020;58(2):185-191.
17. Yamaji H, Murakami T, Hina K, et al. Differences in activated
clotting time and initial heparin dosage during atrial fibrillation
ablation for patients with edoxaban compared with warfarin. J
Cardiovasc Electrophysiol. 2018;29(6):835-843.
18. Armbruster HL, Lindsley JP, Moranville MP, et al. Safety of novel
oral anticoagulants compared with uninterrupted warfarin for catheter
ablation of atrial fibrillation. Ann Pharmacother.2015;49(3):278-284.
19. Yamaji H, Murakami T, Hina K, et al. Adequate Initial Heparin Dosage
for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K
Antagonist Oral Anticoagulants. Clin Drug Investig.2016;36(10):837-848.
20. Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus
formation with cryoenergy versus radiofrequency catheter ablation.Circulation. 2003;107(15):2045-2050.
21. Neumann T, Kuniss M, Conradi G, et al. MEDAFI-Trial
(Micro-embolization during ablation of atrial fibrillation): comparison
of pulmonary vein isolation using cryoballoon technique vs.
radiofrequency energy. Europace. 2011;13(1):37-44.
22. Herrera Siklody C, Deneke T, Hocini M, et al. Incidence of
asymptomatic intracranial embolic events after pulmonary vein isolation:
comparison of different atrial fibrillation ablation technologies in a
multicenter study. J Am Coll Cardiol. 2011;58(7):681-688.
23. Nakamura T, Okishige K, Kanazawa T, et al. Incidence of silent
cerebral infarctions after catheter ablation of atrial fibrillation
utilizing the second-generation cryoballoon. Europace.2017;19(10):1681-1688.
24. Su W, Kowal R, Kowalski M, et al. Best practice guide for
cryoballoon ablation in atrial fibrillation: The compilation experience
of more than 3000 procedures. Heart Rhythm. 2015;12(7):1658-1666.
25. Fortuni F, Casula M, Sanzo A, et al. Meta-Analysis Comparing
Cryoballoon Versus Radiofrequency as First Ablation Procedure for Atrial
Fibrillation. Am J Cardiol. 2020;125(8):1170-1179.
26. Jin ES, Wang PJ. Cryoballoon Ablation for Atrial Fibrillation: a
Comprehensive Review and Practice Guide. Korean Circ J.2018;48(2):114-123.
27. Cardoso R, Mendirichaga R, Fernandes G, et al. Cryoballoon versus
Radiofrequency Catheter Ablation in Atrial Fibrillation: A
Meta-Analysis. J Cardiovasc Electrophysiol.2016;27(10):1151-1159.
28. Di Biase L, Burkhardt JD, Santangeli P, et al. Periprocedural stroke
and bleeding complications in patients undergoing catheter ablation of
atrial fibrillation with different anticoagulation management: results
from the Role of Coumadin in Preventing Thromboembolism in Atrial
Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE)
randomized trial. Circulation. 2014;129(25):2638-2644.
29. De Ponti R, Cappato R, Curnis A, et al. Trans-septal catheterization
in the electrophysiology laboratory: data from a multicenter survey
spanning 12 years. J Am Coll Cardiol. 2006;47(5):1037-1042.
30. Mugnai G, Irfan G, de Asmundis C, et al. Complications in the
setting of percutaneous atrial fibrillation ablation using
radiofrequency and cryoballoon techniques: A single-center study in a
large cohort of patients. Int J Cardiol. 2015;196:42-49.
Table1. Baseline characteristics in enrolled patients